At Biocon, we focus on three core therapeutic areas—Diabetes, Oncology and Immunology—and address some of the world’s most urgent healthcare needs. Through deep scientific expertise, world-class R&D, and a robust global infrastructure, we advance high-quality biosimilars that make essential treatments more affordable and accessible.
Our therapies help manage chronic and complex diseases for millions of patients. Building on this foundation, we are expanding our pipeline into Ophthalmology and Bone Health to further address unmet medical needs and improve health outcomes.
